期刊文献+

血ADM TGF-β1在2型糖尿病肾病患者的变化及意义 被引量:1

The Change of Serum ADM TGF-β1 and its Clinical Sgnificance in Type Ⅱ Diabetics Nephropathy
下载PDF
导出
摘要 目的:探讨血清ADM、TGF-β1在各期糖尿病肾病中的变化及在糖尿病肾病进展中的临床意义。方法:67例2型糖尿病患者根据24 h尿白蛋白排泄率(UAER)分为3组:正常蛋白尿组、微量蛋白尿组和临床蛋白尿组。分别检测糖尿病组和20例正常对照组血清ADM、TGF-β1水平。结果:①糖尿病组血ADM、TGF-β1较正常对照组明显增高(P<0.05)。②微量蛋白尿组血ADM、TGF-β1较正常蛋白尿组明显增高(P<0.05),临床蛋白尿组血ADM、TGF-β1较微量蛋白尿组明显增高(P<0.05)。③血ADM、TGF-β1与UAER呈正相关(r=0.674,P<0.01)。结论:①血ADM、TGF-β1可能在糖尿病肾病发病中起重要作用。②糖尿病正常蛋白尿组血ADM即升高,血ADM可能成为更早期糖尿病肾病的敏感指标,对监测肾病进展有重要意义。 Objective: To test the change of serum ADM,transforming growth factor beta- β1(TGF- β1 ) and investigate their clinical significances in type 2 diabetic nephropathy(DN). Method: 67 cases of patients with type 2 diabetes according to their urinary albumin excretion rate (UAER) were divided into three groups: normal albuminuria group, microalbuminuria group and clinical proteinuria. Serum ADM,TGF- 61 levels were detected in 67 patients with type 2 diabetes and 20 normal controls. Result : ① Serum ADM,TGF - 131 levels significantly increased in diabetic patients compared with that in normal controls(P〈 0.05). ②Serum ADM,TGF- β1 in microalbuminuria group was significantly higher than that of normal albuminuria group(P 〈 0.05). Com- pared with microalbuminuria group, Serum ADM,TGF- β1 was significantly higher in clinical proteinuria group ( P 〈 0.05 ). ③ Serum ADM, TGF - β1 levels was highly correlated wit h UAER ( r = 0.674, P 〈 0.01 ). Conclusion: (DADM,TGF- β1 was probably involved in the process of pathophysiology in type 2 diabetic nephropathy. QSerum ADM was significantly increased in normal albuminuria group and it might be an early marker for predicting diabetic nephropathy and assessing its severity.
出处 《内蒙古医学杂志》 2011年第11期1294-1296,共3页 Inner Mongolia Medical Journal
关键词 糖尿病肾病 转化生长因子-Β1 尿白蛋白 Diabetic nephropathy Adrenomedullin Urinary albumin excretion rate
  • 相关文献

参考文献6

二级参考文献29

  • 1黄志芳,伦立德,季康.内皮素-1对人系膜细胞MMP-3、TIMP-1蛋白表达的影响[J].基础医学与临床,2006,26(1):66-69. 被引量:4
  • 2Ruilope LM. Valsartan and the kidney: review of preclinieal and clinical data[J]. Adv Ther, 2001,18(2) :57 - 66.
  • 3Moontuenga LM, Mariano JM, Prentice MA, et al. Coordinate expression of transforming growth factor - beta 1 and adrenomedullin in rodent embryogenesis [ J ]. Endocrinology,1998,139(9) :3946 - 3957.
  • 4Klahr S, Morrissey J. Angiotensin Ⅱ gene expression in the kidney[J]. Am J Kidney Dis, 1998,31(1):171- 176.
  • 5Ruilope LM. Valsartan and the kidney: review of preclinical and clinical data[J]. Adv Ther, 2001,18(2):57-66.
  • 6Moonmenga LM, Mariano JM, Prentice MA, et al. Coordinate expression of transforming growth factor - beta 1 and adrenomedullin in rodent embryogenesis [ J ]. Endocrinology,1998,139(9) :3946 - 3957.
  • 7Klahr S, Morrissey J. Angiotensin Ⅱ gene expression in the kidney [ J ]. Am J Kidney Dis, 1998,31 ( 1 ): 171 - 176.
  • 8Shimosawa T, Fujita T. Adrenomedullin and its related peptide[J]. Endocr J, 2005,52:1-10.
  • 9Hinson JP, Kapas S, Smith DM. Adrenomedullin, a multifunctional regulatory peptide[J]. Endocrine Reviews, 1999,21:138-167.
  • 10Kelly DJ, Zhang YUAN, Hepper C, et al. Protein kinase C beta inhibition attenuates the progression of experimental diabetic nephropathy in the presence of continued hypertension[J]. Diabetes, 2003,52:512-518.

共引文献6

同被引文献4

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部